LobbyingMedecins Sans Frontieres D/B/A Doctors Without Borders lobbying by quarter
Medecins Sans Frontieres D/B/A Doctors Without Borders's latest lobbying report covers Q2 2026, at $337.4K. The four quarters Q4 2025–Q3 2026 total $630.9K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Medecins Sans Frontieres D/B/A Doctors Without Borders
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $630.9K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $27.4K | 1 |
| Q1 2023 | $38.5K | 1 |
| Q2 2023 | $62.7K | 1 |
| Q3 2023 | $54.3K | 1 |
| Q4 2023 | $91.5K | 1 |
| Q1 2024 | $96.9K | 1 |
| Q2 2024 | $67.4K | 1 |
| Q3 2024 | $62.7K | 1 |
| Q4 2024 | $85.8K | 1 |
| Q1 2025 | $110.4K | 1 |
| Q2 2025 | $104.4K | 1 |
| Q3 2025 | $119.6K | 1 |
| Q4 2025 | $110K | 1 |
| Q1 2026 | $183.5K | 1 |
| Q2 2026 | $337.4K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.6M · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE15 reports
- HOUSE OF REPRESENTATIVES13 reports
- Centers For Disease Control & Prevention (CDC)12 reports
- State, Dept of (DOS)12 reports
- Health & Human Services, Dept of (HHS)11 reports
- Natl Institutes of Health (NIH)10 reports
- U.S. Agency for International Development (USAID)8 reports
- Natl Security Council (NSC)5 reports
- Defense, Dept of (DOD)3 reports
- Office of Science & Technology Policy (OSTP)2 reports
- U.S. International Trade Commission (ITC)2 reports
- Commerce, Dept of (DOC)1 reports
- Government Accountability Office (GAO)1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseMedecins Sans Frontieres D/B/A Doctors Without Borders | $1.6M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $337.4K |
| 04/20for Q1 | In-house | $183.5K |
| 04/17for Q1 | In-house | $140.1K |
| 01/13for Q4 2025 | In-house | $110K |
| 25/10/08for Q3 2025 | In-house | $119.6K |
| 25/07/18for Q2 2025 | In-house | $104.4K |
| 25/04/17for Q1 2025 | In-house | $110.4K |
| 25/01/14for Q4 2024 | In-house | $85.8K |
| 24/10/17for Q3 2024 | In-house | $62.7K |
| 24/07/19for Q2 2024 | In-house | $67.4K |
| 24/04/12for Q1 2024 | In-house | $96.9K |
| 24/01/19for Q4 2023 | In-house | $91.5K |
| 23/10/06for Q3 2023 | In-house | $54.3K |
| 23/07/07for Q2 2023 | In-house | $62.7K |
| 23/04/18for Q1 2023 | In-house | $38.5K |
| 23/01/20for Q4 2022 | In-house | $27.4K |